GL
EW icon

GLG LLC’s Edwards Lifesciences EW Stock Holding History

GLG LLC’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-33,531
Closed -$1.05M – 557
2016
Q4 		$1.05M Buy
33,531
+2,133
+7% +$69.1K 0.07% 267
2016
Q3 		$1.26M Sell
31,398
-1,653
-5% -$62.3K 0.09% 242
2016
Q2 		$1.1M Sell
33,051
-912
-3% -$31.2K 0.08% 251
2016
Q1 		$999K Sell
33,963
-6,024
-15% -$166K 0.06% 305
2015
Q4 		$1.05M Sell
39,987
-22,983
-36% -$597K 0.06% 297
2015
Q3 		$1.49M Sell
62,970
-108
-0.2% -$2.61K 0.04% 360
2015
Q2 		$1.5M Sell
63,078
-234
-0.4% -$5.28K 0.03% 401
2015
Q1 		$1.5M Sell
63,312
-1,044
-2% -$23.4K 0.04% 371
2014
Q4 		$1.37M Hold
64,356
– – 0.04% 396
2014
Q3 		$1.1M Hold
64,356
– – 0.03% 476
2014
Q2 		$921K Hold
64,356
– – 0.03% 521
2014
Q1 		$796K Buy
+64,356
New +$743K 0.03% 521

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

GLG LLC's EW Position: Q1 2017 in Review

GLG LLC sold out of Edwards Lifesciences (EW) in Q1 2017, closing a stake of 33,531 shares — an estimated $1.05M sold.

GLG LLC first reported a position in EW in Q1 2014 and held it in 12 quarters. The position peaked at $1.5M in Q1 2015. 691 funds tracked by Wall St. Rank hold EW as of Q1 2017.

  • GLG LLC reported no remaining Edwards Lifesciences position as of Q1 2017 after selling out during the quarter.
  • GLG LLC sold 33,531 Edwards Lifesciences shares in Q1 2017, an estimated $1.05M.
  • GLG LLC first reported a position in Edwards Lifesciences in Q1 2014 and held it in 12 quarters.
  • GLG LLC's Edwards Lifesciences position peaked at $1.5M in Q1 2015.
  • 691 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on GLG LLC's 13F filing for Q1 2017, filed 15 May 2017.